Scarica l'app Stockscreener
0.312
5.45%
-0.018
Pre-mercato:
.31
-0.002
-0.64%
Precedente Chiudi:
$0.33
Aprire:
$0.33
Volume 24 ore:
106.09K
Relative Volume:
0.02
Capitalizzazione di mercato:
$1.95M
Reddito:
-
Utile/perdita netta:
$-16.89M
Rapporto P/E:
-0.0149
EPS:
-20.8847
Flusso di cassa netto:
$-16.44M
1 W Prestazione:
-14.26%
1M Prestazione:
-52.73%
6M Prestazione:
-91.94%
1 anno Prestazione:
-95.24%
Intervallo 1D:
$0.3071
$0.33
Intervallo di 1 settimana:
$0.3071
$0.37
Portata 52W:
$0.2907
$14.14
Glucotrack Inc Stock (GCTK) Company Profile
Nome
Glucotrack Inc
Settore
Industria
Telefono
972 (8) 675-7878
Indirizzo
301 RT 17 NORTH, RUTHERFORD
Compare GCTK vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
GCTK
Glucotrack Inc
|
0.312 | 2.07M | 0 | -16.89M | -16.44M | -20.88 |
ISRG
Intuitive Surgical Inc
|
405.97 | 143.33B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
155.19 | 42.96B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
39.61 | 32.87B | 29.14B | 1.07B | 1.05B | 1.1956 |
ALC
Alcon Inc
|
67.61 | 33.07B | 10.63B | 819.00M | 1.59B | 1.6577 |
RMD
Resmed Inc
|
198.43 | 29.05B | 5.54B | 1.52B | 1.74B | 10.37 |
Glucotrack Inc Borsa (GCTK) Ultime notizie
GCTK Stock Is Soaring Today — What Is Fueling The Surge? - Stocktwits
GlucoTrack Inc (GCTK) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey
Price to sales forward of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
Price to book forward of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
GlucoTrack Inc (GCTK) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
GlucoTrack Inc (GCTK) Institutional Confidence - TradingKey
GlucoTrack Inc (GCTK) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
GlucoTrack Inc (GCTK) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
GlucoTrack Inc (GCTK) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
GlucoTrack Inc (GCTK) Valuation: PE, PB & Fair Value Analysis - TradingKey
GlucoTrack Inc (GCTK) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
GlucoTrack Inc (GCTK) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Glucotrack (NASDAQ: GCTK) seeks reverse split, warrant repricing and auditor ratification - Stock Titan
EBIT per share of GlucoTrack, Inc. – NASDAQ:GCTK - TradingView
GLUCOTRACK INC (GCTK) Stock Chart - ChartMill
GCTK Stock Price, Quote & Chart | GLUCOTRACK INC (NASDAQ:GCTK) - ChartMill
Glucotrack CEO explains tech behind long-term CBGM implant - Drug Delivery Business
GCTKGlucoTrack Inc Stock Price and Quote - Finviz
Glucotrack Inc Highlights Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association 2026 Scientific Sessions - marketscreener.com
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association’s 2026 Scientific Sessions - The Manila Times
Glucotrack to Highlight Implantable Continuous Blood Glucose Monitoring Technology at the American Diabetes Association's 2026 Scientific Sessions - Moomoo
Implantable glucose sensor designed for multi-year use without wearables - Stock Titan
GlucoTrack Inc. (GCTK) Surges 8%: Testing Key Resistance at $0.53PCR Spike - The Legal Advocate
GlucoTrack Inc. (GCTK) Rallies 8.23% as Shares Test Key Resistance LevelBlock Trade Flow - thelegaladvocate.com
GlucoTrack Inc. (GCTK) Rebounds Sharply: Bullish Momentum Building Above SupportContinuation Pattern Picks - The Legal Advocate
12 Health Care Stocks Moving In Wednesday's Intraday Session - Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga
12 Health Care Stocks Moving In Monday's Intraday Session - Sahm
GlucoTrack Faces Multiple Nasdaq Deficiency Notices, Delisting Risk - TipRanks
Glucotrack receives Nasdaq delisting notice over listing rule deficiencies By Investing.com - Investing.com South Africa
Glucotrack receives Nasdaq delisting notice over listing rule deficiencies - Investing.com
Glucotrack Received Notice of Delisting - TradingView
Glucotrack (GCTK) cited for bid price and equity Nasdaq deficiencies - Stock Titan
Armistice Capital (GCTK) reports 102,115 shares, 4.99% ownership - Stock Titan
Glucotrack Reports Q1 2026 Results and Advances IDE Submission for Implantable Glucose Monitor - Minichart
Glucotrack's 3-Year CGM Aims to Revolutionize Diabetes Management - BriefGlance
TradingKey - TradingKey
Glucotrack 1Q Loss/Shr $2.65 >GCTK - Moomoo
Glucotrack Reports Q1 2026 Net Loss of $4.3M, Cash $3.9M, Files IDE for Implantable CBGM - TradingView
Glucotrack, Inc. Q1 2026: Net loss $(4.33M), EPS $(2.65) — 10-Q Summary - TradingView
Glucotrack, Inc. Submits IDE Application to FDA for Implantable Continuous Blood Glucose Monitoring System and Reports Q1 2026 Financial Results - Quiver Quantitative
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - The Manila Times
GlucoTrack, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026 - marketscreener.com
Glucotrack (GCTK) posts Q1 loss as cash tightens and Nasdaq flags delisting - Stock Titan
Glucotrack (NASDAQ: GCTK) Q1 2026 results, IDE filing and cash runway - Stock Titan
Glucotrack Reports First Quarter 2026 Financial Results and Recent Corporate Highlights - GlobeNewswire Inc.
GlucoTrack Stock Short Interest Rises to 59.4% - Moomoo
GlucoTrack, Sarepta, TNF Pharma Dominate Weekly Retail Health Care Buzz — Here’s Why - MSN
What you need to know before buying GlucoTrack (GCTK) (+0.76%) 2026-05-08Mid Cap Momentum - newser.com
How GlucoTrack (GCTK) maintains its asset base | GCTK: GlucoTrack Q Results Lack Revenue, EPS DataFinancial Summary - newser.com
GlucoTrack Files IDE for Implantable Glucose Monitor - TipRanks
Glucotrack Inc Azioni (GCTK) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.09%
0.52%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):